The U.S. Centers for Medicare and Medicaid Services (CMS) has approved a New Technology Add-on Payment (NTAP) for Aidoc's Clinical AI Reasoning Engine (CARE) Body CT Multi-Triage AI device.
This provides a Medicare Fee-For-Service add-on payment for eligible inpatient use beginning October 1, according to Aidoc.
The NTAP designation means qualifying Medicare Fee-For-Service inpatient cases using the device will be eligible for reimbursement over the next three years. CARE Body CT Multi-Triage has regulatory clearance to assist with workflow triage by flagging suspected findings across urgent conditions on contrast and non-contrast CT studies of the chest, abdomen, and pelvis. The device received Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) in September 2025 and FDA clearance in January.
Aidoc said the NTAP approval represents a novel reimbursement decision for AI software built on a healthcare foundation model.
